Skip to content
Regulatory Consulting
Active Ingredients
Tax Compliance
About Us
Resources
News & Press
Insights
Events & Publications
TSRC 2021
TSRC 2022
TSRC 2023
TSRC 2024
TSRC 2025
TSRC 2026
TPE 2024
FDLI 2024
Contact Us
WHERE POPULATION-LEVEL HEALTH BENEFIT IS OFTEN FORGOTTEN
Purpose of Research
FDA CTP deficiency response
Candidate product benefit & APPH standard
Going beyond the APPH standard & regulatory requirements
The individual vs. the population
Research Objectives, Methods, & Design
Aggregate Population/Study Sample-Level Results
Considering the Individual
Download PDF
Event Name:
TSRC 2025
Event Date:
September 18, 2025
Team:
Dr. Jessica Zdinak
Explore more events:
September 22, 2022
Salt vs. Free-base Nicotine in E-Liquids Does Not Impact Nicotine Plasma Levels
NICOTINE TOBACCO PRODUCT HAZARD ASSESMENT
Optimizing abuse liability studies for FDA review of novel nicotine products
RESOLUTION OF MICRONUCLEUS INDUCTION GENOTOXICITY IN ENDS: IN VITRO AND IN VIVO TESTING
Page load link
Go to Top